ERBA Diagnostics, Inc. provided earnings guidance for the year ended December 31, 2012. For the period, the company expects revenues of approximately $19,500,000 compared to revenues of $16,759,773 for the year ended December 31, 2011. Net loss of approximately $1,100,000 compared to net loss of $3,297,343 for the year ended December 31, 2011.
ERBA Diagnostics, Inc.
Equities
ERBA
US29490B1017
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-6.13% | 182B | |
-1.06% | 108B | |
-5.40% | 67.62B | |
-7.85% | 46.61B | |
+12.17% | 45.32B | |
+6.47% | 42.11B | |
+20.16% | 31.17B | |
+13.26% | 25.66B | |
-3.92% | 24.65B |